title: Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain.
abstract: The mRen(2).Lewis (mRen2) strain is an ANG II-dependent model of hypertension expressing marked sex differences in blood pressure and tissue injury that also exhibits estrogen and salt sensitivity. Because estrogen and salt influence angiotensinogen (AGT), circulating and renal expression of the protein were assessed in the mRen2 using a sensitive and specific ELISA. Hemizygous female and male mRen2 were placed on normal (1% NaCl, NS)- or high (8% NaCl, HS)-salt diets from 5 to 15 wk of age while a separate NS cohort was ovariectomized (OVX). The OVX mRen2 exhibited higher blood pressure (184 +/- 6 vs. 149 +/- 5 mmHg, n = 6), a 16-fold increase in urinary AGT (uAGT) (0.2 +/- 0.02 vs. 0.01 +/- 0.01 microg x kg(-1) x day(-1), P < 0.01), but no change in proteinuria (PROT). Excretion of AGT was correlated with blood pressure and PROT in the female groups. The HS diet led to higher blood pressure (224 +/- 8 mmHg), a 180-fold increase in uAGT (1.8 +/- 0.2 microg x kg(-1) x day(-1)), and increased PROT (98 +/- 9 vs. 7 +/- 1 mg x kg(-1) x day(-1)). Compared with females, NS males expressed higher excretion of uAGT (3.0 +/- 0.4 microg x kg(-1) x day(-1)) and PROT (32 +/- 5 mg x kg(-1) x day(-1)); both were increased eightfold with HS (uAGT: 23 +/- 3 microg x kg(-1) x day(-1); PROT: 285 +/- 28 mg x kg(-1) x day(-1)) without a change in blood pressure. Although uAGT was markedly higher in the OVX and HS groups, neither renal cortical AGT mRNA or protein expression was increased. Moreover, AGT release in cortical slices was similar for the NS and HS females. We conclude that the increase in uAGT with estrogen depletion or HS likely may be a biomarker for glomerular damage reflecting filtration of the circulating protein in the mRen2.
authors.affiliation: Hypertension and Vascular Research Center, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157-1095, USA.
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Cohen
authors.forename: Sarah H
authors.initials: SH
authors.lastname: Lindsey
authors.forename: Nancy T
authors.initials: NT
authors.lastname: Pirro
authors.forename: K Bridget
authors.initials: KB
authors.lastname: Brosnihan
authors.forename: Patricia E
authors.initials: PE
authors.lastname: Gallagher
authors.forename: Mark C
authors.initials: MC
authors.lastname: Chappell
mesh_terms: D000808:Angiotensinogen / Q000097:blood / Q000235:genetics / Q000378:metabolism* / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001794:Blood Pressure; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D006973:Hypertension / Q000209:etiology / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D007668:Kidney / Q000378:metabolism*; D008297:Male; D051379:Mice; D010052:Ovariectomy; D011507:Proteinuria / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D055647:Rats, Transgenic; D012083:Renin / Q000235:genetics*; D012737:Sex Factors; D017673:Sodium Chloride, Dietary / Q000009:adverse effects*; D013997:Time Factors; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D004967:Estrogens; D012333:RNA, Messenger; C473112:Ren2 protein, mouse; D017673:Sodium Chloride, Dietary; D000808:Angiotensinogen; D012083:Renin
references.citation: Hypertension. 2003 Oct;42(4):781-6
references.pmid: 12874087
references.citation: Hypertension. 1992 May;19(5):456-63
references.pmid: 1568764
references.citation: Physiol Genomics. 1999 Jul 15;1(1):3-9
references.pmid: 11015555
references.citation: Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1220-6
references.pmid: 18287217
references.citation: Regul Pept. 1999 Mar 17;80(1-2):57-66
references.pmid: 10235635
references.citation: J Am Soc Nephrol. 2002 Nov;13(11):2681-7
references.pmid: 12397037
references.citation: Am J Physiol Renal Physiol. 2009 Apr;296(4):F771-9
references.pmid: 19211690
references.citation: J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S189-95
references.pmid: 9892162
references.citation: Cardiovasc Res. 2002 Feb 15;53(3):672-7
references.pmid: 11861038
references.citation: Pharmacol Rev. 2007 Sep;59(3):251-87
references.pmid: 17878513
references.citation: Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H767-72
references.pmid: 15059772
references.citation: J Gerontol A Biol Sci Med Sci. 2008 Jan;63(1):3-11
references.pmid: 18245755
references.citation: Am J Physiol Renal Physiol. 2004 May;286(5):F965-71
references.pmid: 15075192
references.citation: Am J Physiol Renal Physiol. 2008 May;294(5):F1257-63
references.pmid: 18353869
references.citation: Am J Nephrol. 2010;31(4):318-25
references.pmid: 20160435
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H10-20
references.pmid: 18456730
references.citation: Braz J Med Biol Res. 1999 Apr;32(4):373-81
references.pmid: 10347798
references.citation: J Am Soc Nephrol. 2008 Feb;19(2):269-80
references.pmid: 18057217
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1557-63
references.pmid: 16825422
references.citation: Am J Med Sci. 2009 Dec;338(6):478-80
references.pmid: 19884815
references.citation: Hypertension. 2002 Feb;39(2 Pt 2):316-22
references.pmid: 11882566
references.citation: Kidney Int. 2009 Jan;75(2):156-66
references.pmid: 18923387
references.citation: Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1606-12
references.pmid: 10845879
references.citation: Kidney Int. 2006 Mar;69(6):1016-23
references.pmid: 16528251
references.citation: Kidney Int. 2005 Nov;68(5):2189-96
references.pmid: 16221218
references.citation: Am J Physiol. 1997 Mar;272(3 Pt 2):F405-9
references.pmid: 9087685
references.citation: J Clin Invest. 1989 Jun;83(6):1941-5
references.pmid: 2723066
references.citation: Physiol Rev. 2006 Jul;86(3):747-803
references.pmid: 16816138
references.citation: Gend Med. 2008;5 Suppl A:S65-75
references.pmid: 18395684